Peripartum Cardiomyopathy: Recent Insights in its Pathophysiology

Brar, 2007, Incidence, mortality, and racial differences in peripartum cardiomyopathy, Am J Cardiol, 100, 302, 10.1016/j.amjcard.2007.02.092 Cataldo, 2000, Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells, Int J Oncol, 17, 1179 Cenac, 1993, Peripartum dilated cardiomyopathy. A model of multifactor disease?, Rev Med Interne, 14, 1033 Cole, 1987, Longitudinal changes in left ventricular architecture and function in peripartum cardiomyopathy, Am J Cardiol, 60, 871, 10.1016/0002-9149(87)91039-3 Corbacho, 2002, Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis, J Endocrinol, 173, 219, 10.1677/joe.0.1730219 Diwan, 2008, Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation, Circulation, 117, 396, 10.1161/CIRCULATIONAHA.107.727073 Eghbali, 2005, Molecular and functional signature of heart hypertrophy during pregnancy, Circ Res, 96, 1208, 10.1161/01.RES.0000170652.71414.16 Eghbali, 2006, Heart hypertrophy during pregnancy: a better functioning heart?, Trends Cardiovasc Med, 16, 285, 10.1016/j.tcm.2006.07.001 Elkayam, 2005, Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation, Circulation, 111, 2050, 10.1161/01.CIR.0000162478.36652.7E Ellis, 2005, Inhibition of progenitor dendritic cell maturation by plasma from patients with peripartum cardiomyopathy: role in pregnancy-associated heart disease, Clin Dev Immunol, 12, 265, 10.1080/17402520500304352 Fett, 2002, Peripartum cardiomyopathy. Insights from Haiti regarding a disease of unknown etiology, Minn Med, 85, 46 Fett, 2007, Viral infection as a possible trigger for the development of peripartum cardiomyopathy, Int J Gynaecol Obstet, 97, 149, 10.1016/j.ijgo.2007.01.012 Fett, 2002, Mother–daughter peripartum cardiomyopathy, Int J Cardiol, 86, 331, 10.1016/S0167-5273(02)00357-1 Ge, 2008, Association of common JAK2 variants with body fat, insulin sensitivity and lipid profile, Obesity, 16, 492, 10.1038/oby.2007.79 Goland, 2007, Pregnancy-associated spontaneous coronary artery dissection, Am J Obstet Gynecol, 197, e11, 10.1016/j.ajog.2007.08.054 Gonzalez, 2004, 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation, Endocrinology, 145, 5714, 10.1210/en.2004-0647 Harrison, 1979, Suppression of lactation, Semin Perinatol, 3, 287 Hayakawa, 2003, Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice, Circulation, 108, 3036, 10.1161/01.CIR.0000101920.72665.58 Hilfiker-Kleiner, 2007, A cathepsin D-cleaved 16-kDa form of prolactin mediates postpartum cardiomyopathy, Cell, 128, 589, 10.1016/j.cell.2006.12.036 Hilfiker-Kleiner, 2007, Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine, J Am Coll Cardiol, 50, 2354, 10.1016/j.jacc.2007.10.006 Hopp, 1996, Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement, Int J Cardiol, 57, 227, 10.1016/S0167-5273(96)02789-1 Houstis, 2006, Reactive oxygen species have a causal role in multiple forms of insulin resistance, Nature, 440, 944, 10.1038/nature04634 Ito, 2007, STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma, Journal of Clinical Oncology, 25, 2785, 10.1200/JCO.2006.09.8897 James, 2005, Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy, Clin Adv Hematol Oncol, 3, 187 Kim, 2005, Oxidative stress-related gene polymorphism and the risk of preeclampsia, European Journal of Obstetrics, Gynecology, and Reproductive Biology, 119, 42, 10.1016/j.ejogrb.2004.06.009 Kothari, 1997, Aetiopathogenesis of peripartum cardiomyopathy: prolactin–selenium interaction?, Int J Cardiol, 60, 111, 10.1016/S0167-5273(96)02906-3 Lee, 2007, 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway, Cancer Res, 67, 11045, 10.1158/0008-5472.CAN-07-0986 Macotela, 2006, Matrix metalloproteases from chondrocytes generate an antiangiogenic 16-kDa prolactin, J Cell Sci, 119, 1790, 10.1242/jcs.02887 Mayosi, 2007, Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa, Heart, 93, 1176, 10.1136/hrt.2007.127746 Nagafuchi, 1999, Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis, J Rheumatol, 26, 1890 Negoro, 2001, Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase, Circulation, 104, 979, 10.1161/hc3401.095947 Patten, 2004, 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling, Circ Res, 95, 692, 10.1161/01.RES.0000144126.57786.89 Patti, 1999, Myocardial infarction during pregnancy and postpartum: a review, G Ital Cardiol, 29, 333 Pearson, 2000, Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review, JAMA, 283, 1183, 10.1001/jama.283.9.1183 Reimold, 2001, Peripartum cardiomyopathy, N Engl J Med, 344, 1629, 10.1056/NEJM200105243442110 Rizeq, 1994, Incidence of myocarditis in peripartum cardiomyopathy, Am J Cardiol, 74, 474, 10.1016/0002-9149(94)90906-7 Roberg, 1998, Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes, Am J Pathol, 152, 1151 Schulz, 2007, Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches, Annu Rev Pharmacol Toxicol, 47, 211, 10.1146/annurev.pharmtox.47.120505.105230 Sliwa, 2006, Peripartum cardiomyopathy, Lancet, 368, 687, 10.1016/S0140-6736(06)69253-2 Sliwa, 2006, Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients, Eur Heart J, 27, 441, 10.1093/eurheartj/ehi481 Sliwa K, Forster O, Zhanje F, et al., 2004. Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 93:1441-1443, A10. Sliwa, 2000, Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1, J Am Coll Cardiol, 35, 701, 10.1016/S0735-1097(99)00624-5 Sliwa, 2002, The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy, Eur J Heart Fail, 4, 305, 10.1016/S1388-9842(02)00008-9 Tabruyn, 2007, The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via NF-{kappa}B activation, Mol Endocrinol, 21, 1422, 10.1210/me.2007-0021 Tabruyn, 2003, The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB, Mol Endocrinol, 17, 1815, 10.1210/me.2003-0132 Toescu, 2002, Oxidative stress and normal pregnancy, Clin Endocrinol (Oxf), 57, 609, 10.1046/j.1365-2265.2002.01638.x Turkalj, 1982, Surveillance of bromocriptine in pregnancy, JAMA, 247, 1589, 10.1001/jama.1982.03320360039028 Van Remmen, 2001, Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis, Am J Physiol Heart Circ Physiol, 281, H1422, 10.1152/ajpheart.2001.281.3.H1422 Yokoyama, 1993, Enhancement of myocardial damage and alteration of lymphocyte subsets in murine model of postpartum myocarditis, Am J Cardiovasc Pathol, 4, 343 Zhang, 2006, Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular disease in dialysis patients, Journal of the American Society of Nephrology, 17, 2285, 10.1681/ASN.2005090985